Alexion, AstraZeneca Rare Disease was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. U.S. Community guidelines: https://t.co/CDq4jNKuoeAlexion is a global biopharmaceutical company focused on developing life-changing therapies for people living with rare disorders.

Core values

- **Addressing Rare Diseases**: Alexion is dedicated to transforming the lives of people affected by rare diseases through the development and commercialization of life-changing medicines. This directly improves the quality of life for patients and their families[5].
- **Medical Education and Patient Advocacy**: They provide grants for medical education and patient advocacy, which support the educational and professional development of healthcare professionals and the needs of patients and caregivers[1].
- **Patient Support**: Programs like OneSource™ and the Global Access to Medicines Policy help with therapy costs, access, and critical services, ensuring that patients can receive the treatments they need[1].
- **Quality and Safety**: Alexion is committed to delivering safe and effective products, complying with regulatory requirements, and maintaining a robust Quality Management System, all of which contribute to patient safety and well-being[2].
- **Diversity, Inclusion, and Belonging**: Their efforts in promoting diversity, inclusion, and belonging create a positive work environment and foster innovation that benefits patients and communities[4].